Literature DB >> 8681386

Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid.

M D Sintchak1, M A Fleming, O Futer, S A Raybuck, S P Chambers, P R Caron, M A Murcko, K P Wilson.   

Abstract

The structure of inosine-5'-monophosphate dehydrogenase (IMPDH) in complex with IMP and mycophenolic acid (MPA) has been determined by X-ray diffraction. IMPDH plays a central role in B and T lymphocyte replication. MPA is a potent IMPDH inhibitor and the active metabolite of an immunosuppressive drug recently approved for the treatment of allograft rejection. IMPDH comprises two domains: a core domain, which is an alpha/beta barrel and contains the active site, and a flanking domain. The complex, in combination with mutagenesis and kinetic data, provides a structural basis for understanding the mechanism of IMPDH activity and indicates that MPA inhibits IMPDH by acting as a replacement for the nicotinamide portion of the nicotinamide adenine dinucleotide cofactor and a catalytic water molecule.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8681386     DOI: 10.1016/s0092-8674(00)81275-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  107 in total

1.  Regulation of an IMP dehydrogenase gene and its overexpression in drug-sensitive transcription elongation mutants of yeast.

Authors:  R J Shaw; J L Wilson; K T Smith; D Reines
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

Review 2.  The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors.

Authors:  L Hedstrom; G Liechti; J B Goldberg; D R Gollapalli
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  Inosine 5'-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo.

Authors:  Jeremy E McLean; Nobuko Hamaguchi; Peter Belenky; Sarah E Mortimer; Martin Stanton; Lizbeth Hedstrom
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

4.  Use of RNA yeast polymerase II mutants in studying transcription elongation.

Authors:  Daniel Reines
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

5.  CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations.

Authors:  John W Scott; Simon A Hawley; Kevin A Green; Miliea Anis; Greg Stewart; Gillian A Scullion; David G Norman; D Grahame Hardie
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

6.  Substantial improvements in large-scale redocking and screening using the novel HYDE scoring function.

Authors:  Nadine Schneider; Sally Hindle; Gudrun Lange; Robert Klein; Jürgen Albrecht; Hans Briem; Kristin Beyer; Holger Claußen; Marcus Gastreich; Christian Lemmen; Matthias Rarey
Journal:  J Comput Aided Mol Des       Date:  2011-12-27       Impact factor: 3.686

7.  Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients.

Authors:  S Uemoto; K Ozawa; T Kaido; A Mori; Y Fujimoto
Journal:  Clin Exp Immunol       Date:  2016-01-11       Impact factor: 4.330

Review 8.  Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapy.

Authors:  Murtaza S Nagree; Lucía López-Vásquez; Jeffrey A Medin
Journal:  World J Stem Cells       Date:  2015-12-26       Impact factor: 5.326

9.  Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells.

Authors:  M Colic; Z Stojic-Vukanic; B Pavlovic; D Jandric; I Stefanoska
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

10.  Brain dead donor kidneys are immunologically active: is intervention justified?

Authors:  G Vergoulas; P Boura; G Efstathiadis
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.